On November 20, 2008, the LRG held its Fifth Annual Poker Tournament at the Midtown Loft on Fifth Avenue in New York City. It is always a remarkable evening and has become a muchlooked- forward-to event for LRG staff and supporters.
GIST patients face many decisions about their treatment. Many GIST patients have surgery to remove a primary tumor and do not have detectable metastases at the time of surgery. This large group of patients faces the decision of whether or not to take Gleevec to try to prevent or delay a recurrence. Adjuvant therapy refers to additional treatment given after a main mode of therapy (the main treatment is usually surgery). For example, Gleevec given after surgery in hopes of preventing or delaying a recurrence is called adjuvant therapy.
Interpreting research: dilemmas facing patients and physicians. Recently, GIST discussion groups have debated the value of the LRG study that examined dosage levels and survival rates. It is important for us to have this debate in [...]
In the span of a few weeks, representatives from the LRG traveled all over the country to attend events and gatherings relevant to the GIST community.
Mrs. Ellen Marie Sarko Heppler, 47, of Jamestown, North Carolina, died on December 7, 2008 at her residence. A native of Cuyahoga County, Ohio, she was born on July 9, 1960, a daughter of James A. and Betty Mash Sarko. Ellen’s family and home were her first love.
Jodi Merry wrote this editorial about GIST Cancer titled When is Enough Enough?
Under different forms, antioxidants are in wide use among health-conscious people and even more so among cancer patients. They take the form of such dietary supplements as Vitamin C, E and A, beta-carotene, lycopene, selenium, ginger (Zingiber officinale), cucurmin (turmeric), or pomegranate juice.
This is a follow-up to an article published in the May 2008 newsletter highlighting the benefits and risks involved in MRIs, PET and CT scans. In the offices of the Life Raft Group, we receive [...]
Recently, concerns about exposure to radiation during scans have stirred significant discussion in the LRG email community. Although this is a decision that must be made between each individual and their treatment team, it [...]
Novartis CEO Dr. Daniel Vasella made the commitment in Boston after hearing a plea from Life Raft Executive Director Norman Scherzer. The $2 million grant is the largest single donation for GIST [...]
